SEC Form 4 · accession 0001179110-15-005349
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Gregory Almstead
Officer — EVP Research Pharma Ops & Tech
Period of report
Mar 19, 2015
Accepted (ET)
Mar 23, 2015 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 19, 2015 | S | 12,000 | $69.36 | D | 17,881 | D | |
| Common StockF3 | Mar 19, 2015 | S | 5,200 | $70.41 | D | 12,681 | D | |
| Common StockF4 | Mar 19, 2015 | S | 1,500 | $71.12 | D | 11,181 | D | |
| Common StockF5 | Mar 19, 2015 | S | 1,670 | $72.52 | D | 9,511 | D | |
| Common Stock | holding | — | — | — | 1,295 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 15, 2014 for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.02 to $69.86 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $70.02 to $71.00 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $71.01 to $71.55 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.01 to $72.84 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.